Stay updated on Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial

Sign up to get notified when there's something new on the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Locations section updated to include Kentucky, Pennsylvania, and Texas, with the page revision updated to v3.3.3.
    Difference
    0.5%
    Check dated 2025-12-23T21:16:52.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added Melanoma and MedlinePlus Genetics as related topics on the study page. These additions serve as metadata for context and indexing.
    Difference
    0.2%
    Check dated 2025-12-02T14:01:22.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.2.0 was removed in the page header, a minor versioning update that does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:10:29.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page deleted the government funding notice and operating status details and removed related topic links (Melanoma; MedlinePlus Genetics). Core study content including title, condition, pembrolizumab intervention, study design, eligibility criteria, and outcomes remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2025-11-18T03:28:19.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The new screenshot shows only minor visual adjustments and slight rearrangement of non-critical sections; core trial details, eligibility criteria, endpoints, and overall study status remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T16:59:20.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    Added related topics: Melanoma and MedlinePlus Genetics, expanding contextual links on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-27T12:20:41.000Z thumbnail image

Stay in the know with updates to Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page.